Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Détails bibliographiques
Auteur principal:	Tamanna, Mst. Taskia
Autres auteurs:	Sharmin, Dr. Sabrina
Format:	Thèse
Langue:	English
Publié:	Brac University 2023
Sujets:	Senile plaques Alzheimer’s disease Apolipoprotein E Bridging integrator 1 Drug development Alzheimer's disease > Treatment > Congresses.
Accès en ligne:	http://hdl.handle.net/10361/18146

Documents similaires

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
par: Hassan, Md. Muhtaz
Publié: (2020)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
par: Alim, Abdul
Publié: (2023)

Marine compounds in the treatment of Alzheimer’s disease
par: Parveen, Sanjana
Publié: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
par: Chowdhury, Sariya Uzrat
Publié: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
par: Shehab, Habibul Mohsin
Publié: (2024)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
par: Aana, Afsara Sumon
Publié: (2021)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
par: Saha, Bithi Rani
Publié: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

Alzheimer's disease and marriage : an intimate account /
par: Wright, Lore K.
Publié: (1993)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
par: Karmaker, Swastika
Publié: (2024)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
par: Nayeem, Abdullah Al
Publié: (2021)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
par: Tasneem, Sadia
Publié: (2021)

Emerging therapies of Alzheimer’s disease: a comprehensive review
par: Tasin, Md Abtahi
Publié: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
par: Aziz, Farhin
Publié: (2019)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
par: Afra, Sumaiya
Publié: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
par: Mostofa, Golam
Publié: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
par: Zaman, Rubaiyat
Publié: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
par: Halim, Rabea
Publié: (2022)

Exploring Alzheimer's disease prediction with XAI in various neural network models
par: Rahman, Quazi Ashikur, et autres
Publié: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
par: Mahee, Sadique Abdal
Publié: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
par: Haque, Mushfiqul
Publié: (2019)

An overview on Covid-19 and invention of its treatment by drugs
par: Nawer, Anika
Publié: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
par: Bakar, Osama Bin Abu
Publié: (2024)

An ambient assisted living system for Alzheimer’s patients
par: Abedin, Minhajul, et autres
Publié: (2023)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
par: Jahan, Nusrat
Publié: (2023)

A review on adult neurogenesis in Alzheimer’s disease
par: Akter, Moriam
Publié: (2022)

Detection of alzheimer's disease using deep learning
par: Hasan, Mahmudul, et autres
Publié: (2021)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
par: Roy, Aditya, et autres
Publié: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
par: Dey, Manashi
Publié: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
par: Sani, Mehedi Hasan, et autres
Publié: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
par: Alam, Badrul, et autres
Publié: (2016)

Role of circular RNA in neurological disease
par: Salsabil, Labiba
Publié: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
par: Mahbub, Riasat, et autres
Publié: (2022)

Skeleton /
par: Parkin, Peter

Drug repurposing in NCDs: benefits and challenges
par: Nasir, Naushin Sadia
Publié: (2021)

Multi-classification based Alzheimer's disease detection with comparative analysis from brain MRI scans using deep learning
par: Kabir, Azmain, et autres
Publié: (2022)

The development and designing of stent for treatment of Atherosclerosis
par: Munni, Monika Nasrin
Publié: (2021)

Early prediction of Alzheimer's disease using convolutional neural network
par: Abed, Mahjabeen Tamanna, et autres
Publié: (2020)